Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2026-01-01 @ 11:45 PM
Study NCT ID:
NCT04713059
Status:
UNKNOWN
Last Update Posted:
2021-07-01
First Post:
2021-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-14
First Submit QC Date:
None
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-29
Last Update Post Date:
2021-07-01
Last Update Post Date Type:
ACTUAL